BARCLAYS PLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$31,000
-36.7%
7,268
-21.1%
0.00%
Q2 2021$49,000
+1533.3%
9,211
+1146.4%
0.00%
Q1 2021$3,000739
+14680.0%
0.00%
Q4 2020$0
-100.0%
5
-99.9%
0.00%
Q3 2020$15,000
-59.5%
4,505
-59.3%
0.00%
Q2 2020$37,000
-19.6%
11,057
-9.7%
0.00%
Q1 2020$46,000
-67.1%
12,243
-47.3%
0.00%
Q4 2019$140,000
+6.1%
23,231
+31.7%
0.00%
Q3 2019$132,000
-84.9%
17,646
-72.7%
0.00%
-100.0%
Q2 2019$875,000
+1246.2%
64,600
+434.0%
0.00%
Q1 2019$65,000
-36.3%
12,098
-64.9%
0.00%
Q4 2018$102,000
-26.1%
34,430
+104.1%
0.00%
Q3 2018$138,000
-8.0%
16,872
+9.6%
0.00%
Q2 2018$150,000
+2.0%
15,400
-9.4%
0.00%
Q1 2018$147,000
+14.0%
16,994
+64.2%
0.00%
Q4 2017$129,000
+143.4%
10,350
+63.6%
0.00%
Q3 2017$53,000
+430.0%
6,327
+910.7%
0.00%
Q2 2017$10,000
-95.2%
626
-94.0%
0.00%
Q1 2017$209,000
+6866.7%
10,400
+2703.2%
0.00%
Q2 2016$3,0003710.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 2,679,457$20,257,0000.73%
Portolan Capital Management 777,293$5,876,0000.66%
CAMPBELL CAPITAL MANAGEMENT INC 110,451$835,0000.62%
ZEKE CAPITAL ADVISORS, LLC 402,212$3,041,0000.27%
Leap Investments LP 46,084$348,0000.17%
Bernardo Wealth Planning LLC 26,419$199,0000.14%
Claraphi Advisory Network, LLC 14,744$111,0000.07%
Sterling Investment Advisors, Ltd. 11,000$83,0000.04%
A.R.T. Advisors, LLC 81,372$615,0000.03%
Mirae Asset Global Investments Co., Ltd. 544,408$4,116,0000.03%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders